Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro

Food and Chemical Toxicology

Volumn 49, Issue 6, 2011, Pages 1410-1415

  Qiao, Jinping ^a   Gu, Chenxin ^a   Shang, Weihu ^a   Du, Jinglei ^a   Yin, Wei ^a   Zhu, Meilin ^a   Wang, Wei ^a   Han, Mei ^a   Lu, Weidong ^b  

^a BEIJING NORMAL UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

5 fluorouracil (5 FU); Cytotoxicity; Green tea; HPLC; Pharmacodynamics; Pharmacokinetics

Indexed keywords

EPIGALLOCATECHIN GALLATE; FLUOROURACIL; GREEN TEA EXTRACT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MONITORING; DRUG POTENTIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIMIT OF QUANTITATION; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; TOXICITY TESTING;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AREA UNDER CURVE; CAMELLIA SINENSIS; CATECHIN; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SYNERGISM; FLUOROURACIL; HUMANS; MALE; NEOPLASMS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 79955664442     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2011.03.033     Document Type: Article

References (36)

1. Camouse M.M., Hanneman K.K., Conrad E.P., Baron E.D. Protective effects of tea polyphenols and caffeine. Expert. Rev. Anticancer Ther. 2005, 5:1061-1068.
2. Chow H.H.S., Cai Y., Hakim I.A., Crowell J.A., Shahi F., Brooks C.A., Dorr R.T., Hara Y., Alberts D.S. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res. 2003, 9:3312-3319.
3. Clement Y. Can green tea do that? A literature review of the clinical evidence. Prev. Med. 2009, 49:83-87.
4. Drynan J.W., Clifford M.N., Obuchowicz J., Kuhnert N. The chemistry of low molecular weight black tea polyphenols. Nat. Prod. Rep. 2010, 27:417-462.
5. Fu T., Liang J., Han G.Z., Lv L., Li N. Simultaneous determination of the major active components of tea polyphenols in rat plasma by a simple and specific HPLC assay. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 875:363-367.
6. Golden E.B., Lam P.Y., Kardosh A., Gaffney K.J., Cadenas E., Louie S.G., Petasis N.A., Chen T.C., Schonthal A.H. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 2009, 113:5927-5937.
7. Hillcoat B.L., McCulloch P.B., Figueredo A.T., Ehsan M.H., Rosenfeld J.M. Clinical response and plasma-levels of 5-fluorouracil in patients with colonic cancer treated by drug infusion. Br. J. Cancer 1978, 38:719-724.
8. Hwang J.T., Ha J., Park I.J., Lee S.K., Baik H.W., Kim Y.M., Park O.J. Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett. 2007, 247:115-121.
9. Iwata S., Takabayashi A., Yamaoka Y. Modulation of intracellular glutathione concentration alters dehydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells. Clin. Exper. Med. 2002, 2:99-103.
10. Jagtap S., Meganathan K., Wagh V., Winkler J., Hescheler J., Sachinidis A. Chemoprotective mechanism of the natural compounds, epigallocatechin-3-o-gallate, quercetin and curcumin against cancer and cardiovascular diseases. Curr. Med. Chem. 2009, 16:1451-1462.
11. Johnson J.J., Bailey H.H., Mukhtar H. Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 2010, 17:3-13.
12. Katiyar S., Elmets C.A., Katiyar S.K. Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair. J. Nutr. Biochem. 2007, 18:287-296.
13. Khan N., Adhami V.M., Mukhtar H. Review: green tea polyphenols in chemoprevention of Prostate Cancer: preclinical and clinical studies. Nutr. Cancer 2009, 61:836-841.
14. Lang M., Henson R., Braconi C., Patel T. Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells. Liver Int. 2009, 29:670-677.
15. Liu J., Xing J., Fei Y. Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies. Chin Med. 2008, 3:12.
16. Longley D.B., Harkin D.P., Johnston P.G. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 2003, 3:330-338.
17. Malet-Martino M., Martino R. Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review. Oncologist 2002, 7:288-323.
18. Masuda M., Suzui N., Weinstein I.B. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res. 2001, 7:4220-4229.
19. Melgarejo E., Urdiales J.L., Sanchez-Jimenez F., Medina M.A. Targeting polyamines and biogenic amines by green tea epigallocatechin-3-gallate. Amino Acids 2010, 38:519-523.
20. Michael A., Hedayati B., Dalgleish A.G. Disease regression in malignant melanoma: Spontaneous resolution or a result of treatment with antioxidants, green tea, and pineapple cores? A case report. Integr. Cancer Ther. 2007, 6:77-79.
21. Milano G., Chamorey A.L. Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics. Chronobiol. Int. 2002, 19:177-189.
22. Moore R.J., Jackson K.G., Minihane A.M. Green tea (Camellia sinensis) catechins and vascular function. Br. J. Nutr. 2009, 102:1790-1802.
23. Mukhtar H., Ahmad N. Tea polyphenols: prevention of cancer and optimizing health. Am. J. Clin. Nutr. 2000, 71:1698S-1702S.
24. Myung, S.K., Bae, W.K., Oh, S.M., Kim, Y., Ju, W., Sung, J., Lee, Y.J., Ko, J.A., Choi, H.J., 2009. Green tea consumption and risk of stomach cancer: A meta-analysis of epidemiologic studies (vol. 124, p. 670, 2009). Int. J. Cancer 124, 1496-1496.
25. Navarro-Peran E., Cabezas-Herrera J., del Campo L.S., Rodriguez-Lopez J.N. Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate. Int. J. Biochem. Cell Biol. 2007, 39:2215-2225.
26. Navolanic P.M., McCubrey J.A. Pharmacological breast cancer therapy (Review). Int. J. Oncol. 2005, 27:1341-1344.
27. Nichols J.A., Katiyar S.K. Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Arch. Dermatol. Res. 2010, 302:71-83.
28. Ogunleye, A.A., Xue, F., Michels, K.B., 2010. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res.Treat. 119.
29. Raza H., John A. In vitro protection of reactive oxygen species-induced degradation of lipids, proteins and 2-deoxyribose by tea catechins. Food Chem. Toxicol. 2007, 45:1814-1820.
30. Saif M.W., Choma A., Salamone S.J., Chu E. Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomes. J. Natl. Cancer Inst. 2009, 101:1543-1552.
31. Sakaeda T., Yamamori M., Kuwahara A., Nishiguchi K. Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy. Adv. Drug Deliv. Rev. 2009, 61:388-401.
32. Tan X.L., Spivack S.D. Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: a review. Lung Cancer 2009, 65:129-137.
33. Vogel S., Presant C., Ratkin G., Klarhr C. Phase I study of infusion 5-fluorouracil (5FU) plus thymidine (T). Proc. Am. Assoc. Cancer Res. 1978, 19:232.
34. Weinstein, I.B., Masuda, M., Suzui, M., Lim, J.T.E., 2003. EGCG targets the epidermal growth factor (EGF) and HER-2 receptors in human cancer cells. Abstr Pap Am Chem Soc 226, AGFD 46.
35. Yang C.S., Landau J.M. Effects of tea consumption on nutrition and health. J. Nutr. 2000, 130:2409-2412.
36. Zhang N., Yin Y., Xu S.J., Chen W.S. 5-fluorouracil: mechanisms of resistance and reversal strategies. Molecules 2008, 13:1551-1569.